Table 3 Association between NAT2 acetylator genotypes with tobacco users and prostate cancer patients.
Tobacco users / non -users | Controls (n = 140) | Ca-Prostate (n = 130) | P-value | Unadjusted OR (95% CI) | Adjusted OR (95% CI) |
|---|---|---|---|---|---|
Non-users | |||||
Slow – acetylator | 43(42.16) | 29 (42.03) | 1.0(Ref) | 1.0(Ref) | |
Rapid-acetylator | 59(57.84) | 40(57.97) | 0.987 | 1.01(0.49–2.11) | 1.04(0.54–2.03) |
Tobacco Users | |||||
Slow – acetylator | 19 (50%) | 17(27.87) | 0.492 | 1.33(0.49–2.47) | 1.45 (0.61–3.46) |
Rapid-acetylator | 19 (50%) | 44(72.13) | 0.001 | 3.43(1.68–7.02) | 4.37(2.02–9.45) |